Johnson & Johnson (JNJ)
186.61
-0.36 (-0.19%)
NYSE · Last Trade: Nov 7th, 10:52 AM EST
FDA adds six drugs to its priority voucher program as CMS and the White House unveil measures to speed reviews and lower prescription costs.
Via Benzinga · November 7, 2025
November 6, 2025 – Global financial markets today demonstrated their profound interconnectedness, as a significant downturn in US stocks rapidly transmitted a wave of apprehension across the Atlantic, leading to a slump in European markets. The sell-off, primarily fueled by escalating concerns over potentially overvalued artificial intelligence (AI) companies and persistent
Via MarketMinute · November 6, 2025
Global financial markets are currently navigating a treacherous landscape of economic uncertainty, with a palpable sense of 'jitters' gripping investors across the United States and Europe. As of November 2025, a complex interplay of factors, including persistent inflation, a cooling labor market, geopolitical tensions, and policy ambiguities, is contributing to
Via MarketMinute · November 6, 2025
The U.S. stock market experienced a notable downturn today, November 6, 2025, as investors grappled with growing apprehension over the lofty valuations of artificial intelligence (AI) stocks and a significantly deteriorating job market. Major indices, including the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average, registered sharp
Via MarketMinute · November 6, 2025
Disclaimer: This article is based on a hypothetical market scenario for November 6, 2025, as real-time future market data is unavailable. The analysis draws upon common drivers of market retreats and their potential implications.
The US stock market is experiencing a significant retreat today, November 6, 2025, as major indices
Via MarketMinute · November 6, 2025
As November 2025 unfolds, the global stock markets find themselves at a critical juncture, struggling to reclaim the robust bullish momentum that characterized much of the preceding years. A palpable shift in investor sentiment is emerging, with an increasing number of market participants questioning the lofty valuations, particularly within the
Via MarketMinute · November 6, 2025
The U.S. economy is currently navigating a perplexing landscape, where a dramatic surge in mass layoffs, marking the highest October job cuts in 22 years, appears to be fueling, rather than hindering, the S&P 500's impressive rally. This "layoffs jump" has seen over 1.1 million jobs cut
Via MarketMinute · November 6, 2025
JNJ gained access to Caplyta with the $14.6 billion acquisition of Intra-Cellular Therapies, Inc., which closed in April.
Via Stocktwits · November 6, 2025
The United States finds itself in an unprecedented economic fog as a prolonged government shutdown, now stretching well into its second month, has brought the flow of critical official data to a grinding halt. With federal agencies responsible for collecting and disseminating vital economic indicators largely shuttered, policymakers, businesses, and
Via MarketMinute · November 5, 2025
The U.S. financial markets have demonstrated remarkable resilience in 2025, staging a significant rebound after experiencing a sharp selloff earlier in the year. The Dow Jones Industrial Average, S&P 500, and Nasdaq Composite, bellwethers of American economic health, have not only recovered lost ground but have also climbed
Via MarketMinute · November 5, 2025
Washington D.C., November 5, 2025 – The United States is grappling with an unprecedented fiscal crisis, as an ongoing government shutdown, now in its 36th day, has officially become the longest in the nation's history. This prolonged political impasse, rooted in fierce partisan disagreements over federal spending and policy riders,
Via MarketMinute · November 5, 2025
Seattle, WA – November 5, 2025 – In a monumental leap for biotechnology and artificial intelligence, Nobel Laureate David Baker’s lab at the University of Washington’s Institute for Protein Design (IPD) has successfully leveraged AI to design antibodies from scratch, achieving unprecedented atomic precision. This groundbreaking development, primarily driven by a sophisticated generative AI model [...]
Via TokenRing AI · November 5, 2025
Growth stocks have outperformed in recent years, but will that continue?
Via The Motley Fool · November 5, 2025
As the financial world turned its attention to November 4th, 2025, markets braced for a day shaped by a confluence of anticipated economic indicators and lingering geopolitical concerns. While specific real-time data for this future date remains beyond immediate reach, a hypothetical analysis suggests a trading session where investor sentiment
Via MarketMinute · November 4, 2025
In the dynamic world of finance, where fortunes are made and lost in the blink of an eye, a chilling sentiment has begun to grip investors: the idea that stocks can, indeed, go down. This isn't merely a theoretical understanding; it's a palpable fear translating into cautious market behavior and
Via MarketMinute · November 4, 2025
New York, NY – November 4, 2025 – Major Wall Street institutions, Goldman Sachs (NYSE: GS) and Morgan Stanley (NYSE: MS), have issued fresh and urgent warnings regarding a potential significant stock market correction. Speaking at the Global Financial Leaders' Investment Summit in Hong Kong today, their top executives articulated growing concerns
Via MarketMinute · November 4, 2025
In a stark warning echoing through the financial markets, U.S. Treasury Secretary Scott Bessent declared this week that the American housing sector is already mired in a recession, directly attributing the downturn to the Federal Reserve's "tight policies." Speaking on CNN, Secretary Bessent called for an accelerated pace of
Via MarketMinute · November 3, 2025
Although Kimberly-Clark suffered a huge blow after announcing its Kenvue buyout, KMB stock is flashing a quantitative contrarian signal.
Via Benzinga · November 3, 2025
November 3, 2025 – The U.S. stock markets are experiencing a significant surge today, with both the S&P 500 and Nasdaq Composite pushing towards new highs. This bullish sentiment is largely fueled by two monumental corporate announcements: a strategic $38 billion partnership between Amazon Web Services (AWS) and OpenAI,
Via MarketMinute · November 3, 2025
Via Benzinga · November 3, 2025
The financial markets have kicked off the week with a significant surge, largely propelled by the blockbuster acquisition of Kenvue Inc. (NYSE: KVUE) by Kimberly-Clark Corporation (NYSE: KMB). This monumental $48.7 billion cash-and-stock deal, announced on November 3, 2025, has sent positive ripples through the stock market, particularly benefiting
Via MarketMinute · November 3, 2025
November 3, 2025, marks a pivotal day in the financial markets, witnessing two seismic corporate announcements that promise to redefine their respective industries. Amazon.com Inc. (NASDAQ: AMZN) has seen its stock surge following a monumental $38 billion cloud services deal with OpenAI, solidifying its position in the fiercely competitive
Via MarketMinute · November 3, 2025
Alvotech shares decline after the FDA issues a complete response letter for its Simponi biosimilar, leading to a lower 2025 revenue and EBITDA outlook.
Via Benzinga · November 3, 2025
New York, NY – November 3, 2025 – The Dow Jones Industrial Average is on track to extend its robust gains as the market closes out a strong trading day, buoyed by a confluence of positive factors including strong corporate earnings, an insatiable appetite for AI-driven technologies, and easing inflation concerns. This
Via MarketMinute · November 3, 2025
Buffett Sells Stocks Please click here for a chart of Warren Buffett’s company Berkshire Hathaway Inc Class B (NYSE:
Via Benzinga · November 3, 2025